These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8916443)
1. The role of current and new discriminating markers in the immunodiagnosis of Hodgkin's disease and other phenotypically related lymphomas. Carbone A; Gloghini A Pathologica; 1996 Jun; 88(3):169-74. PubMed ID: 8916443 [TBL] [Abstract][Full Text] [Related]
2. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Carbone A; Gloghini A; Gruss HJ; Pinto A Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677 [TBL] [Abstract][Full Text] [Related]
4. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Carbone A; Cozzi M; Gloghini A; Pinto A Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease. Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269 [TBL] [Abstract][Full Text] [Related]
6. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508 [TBL] [Abstract][Full Text] [Related]
7. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881 [TBL] [Abstract][Full Text] [Related]
8. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease]. Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865 [TBL] [Abstract][Full Text] [Related]
9. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Carbone A; Gloghini A; Zagonel V; Aldinucci D; Gattei V; Degan M; Improta S; Sorio R; Monfardini S; Pinto A Blood; 1995 Dec; 86(12):4617-26. PubMed ID: 8541553 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study. Nguyen DT; Diamond LW; Hansmann ML; Fischer R Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732 [TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334 [TBL] [Abstract][Full Text] [Related]
12. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis. Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK Blood; 1994 Oct; 84(7):2305-14. PubMed ID: 7522624 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Carbone A; Gloghini A; Volpe R Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287 [TBL] [Abstract][Full Text] [Related]
15. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns? Menestrina F; Chilosi M; Scarpa A Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592 [TBL] [Abstract][Full Text] [Related]
16. CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic large cell (Ki1) lymphoma. Schmidt U; Metz KA; Möser U Tumori; 1998; 84(6):695-700. PubMed ID: 10080680 [TBL] [Abstract][Full Text] [Related]
17. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features. Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761 [TBL] [Abstract][Full Text] [Related]
18. The interface of Hodgkin's disease and anaplastic large cell lymphoma. Chittal SM; Delsol G Cancer Surv; 1997; 30():87-105. PubMed ID: 9547988 [TBL] [Abstract][Full Text] [Related]
19. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease. Hyder DM; Schnitzer B Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118 [TBL] [Abstract][Full Text] [Related]
20. CD30 in normal and neoplastic cells. Chiarle R; Podda A; Prolla G; Gong J; Thorbecke GJ; Inghirami G Clin Immunol; 1999 Feb; 90(2):157-64. PubMed ID: 10080826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]